Research and Markets: Membranous Glomerulonephritis Global Clinical Trials Review, H2, 2015

Research and Markets (http://www.researchandmarkets.com/research/4ls9zg/membranous) has announced the addition of the "Membranous Glomerulonephritis Global Clinical Trials Review, H2, 2015" report to their offering.

This new report provides an overview of Membranous Glomerulonephritis clinical trials scenario. It includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

Clinical Trial Reports are generated using a proprietary database - Pharma eTrack Clinical trials database. The trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe and the database undergoes periodic update by dynamic process.

Scope of the Report:

• The report provides a snapshot of the global clinical trials landscape.
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status.
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company.
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment.
• The Report provides enrollment trends for the past five years.
• Report provides latest news for the past three months.
  

Reasons to buy:

• Assists in formulating key business strategies with regards to investment.
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities.
• Supports understanding of trials count and enrollment trends by country in global therapeutics market.
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials.
• Facilitates clinical trial assessment of the indication on a global, regional and country level.
  

Companies Mentioned:

• GlaxoSmithKline Plc
• Novartis AG
• Hanmi Science Co., Ltd.
• F. Hoffmann-La Roche Ltd.
  

For more information visit http://www.researchandmarkets.com/research/4ls9zg/membranous

View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005074/en/